Phil Masterson

Phil has a BSc in Cell Biology from the University of Essex, and a PhD in Virology from the University of Cambridge. After a post-doc position at the National Institute for Medical Research (NIMR) in London, Phil spent a number of years managing R&D programmes in the biotech industry. 

He moved into technology transfer in 2003 when he joined Cancer Research Horizons (formerly called Cancer Research Technology). Since that time, he has built up extensive experience of managing and commercialising healthcare technologies from academic origins, focusing in recent years on the creation of innovative and transformative oncology ventures, from ideation to launch.  

He has served as a Board Director or Observer for a range of start-up companies including Artios Pharma, Monte Rosa Therapeutics, Infinitopes, MyT BIO, Elaitra and Oncodrug.